腹水超滤浓缩回输联合盐水蛋白治疗顽固腹吸水临床观察

Observation about the Ascites Ultrafiltation Concentration with Salt Protein for Treating Refractory Ascites

目的:观察腹水超滤浓缩回输联合盐水蛋白治疗腹吸水的临床疗效及不良反应。方法:选择肝硬化顽固腹吸水患者20例,试验组:10例,为腹水超滤浓缩回输联合盐水蛋白治疗;对照组:10例,为单纯腹水超滤浓缩回输治疗。结果:两组的腹水均明显消退,试验组更为显著(P<0.05),试验组临床及血清蛋白、肾功能均明显改善,且1个月内无反复。结论:腹水超滤浓缩回输联合盐水蛋白治疗顽固腹吸水疗效显著且安全。

Objective：To study the clinical efficacy and side effect about the ascites ultrafiltation concentration with salt protein for treating refractory ascites.Methods：Choosing 20 patlents：refactory ascites in patients with cirrhosis.Enperimental group：10 patiens,treatment of ascites ultrafiltation concentration with salt protein;Control group：10 patients,simple treatment of ascites reinfusion ultrafiltration.Results：The two Ascites are significantiy dissipated,The experimental group are significantly more（P0.05）,experimental group clinical symptoms and serum protein and renal function are significantly improved,and no recurrent disease within 4 weeks.Conclusion：The ascites ultrafiltation concentration with salt protein was a safe agent for treating refractory ascites.